ATP-binding domains. One vps33 temperature-sensitive mutant contained a missense mutation near this region of sequence similarity; the mutation resulted in a Leu-646 -* Pro substitution in Vps33p. This temperaturesensitive mutant strain contained normal vacuoles at the permissive temperature but lacked vacuoles specifically in the bud at the nonpermissive temperature. Our data suggest that Vps33p acts in the cytoplasm to facilitate Golgi-to-vacuole protein delivery. We propose that as a consequence of the vps33 protein-sorting defects, abnormalities in vacuolar morphology and vacuole assembly result.
sensitive mutant strain contained normal vacuoles at the permissive temperature but lacked vacuoles specifically in the bud at the nonpermissive temperature. Our data suggest that Vps33p acts in the cytoplasm to facilitate Golgi-to-vacuole protein delivery. We propose that as a consequence of the vps33 protein-sorting defects, abnormalities in vacuolar morphology and vacuole assembly result.
Eucaryotic cells contain a number of distinct membraneenclosed organelles whose function and morphology are defined largely by the unique set of proteins residing within them. Thus, mutations that disrupt the accurate sorting of proteins to their correct intracellular locations might also affect the assembly and morphology of the target organelle. Conversely, abnormalities in organelle biogenesis may be manifest as protein trafficking or delivery defects.
In the yeast Saccharomyces cerevisiae, proteins destined for the lysosomelike vacuole traverse the secretory pathway en route to the vacuole. Soluble vacuolar proteins such as carboxypeptidase Y (CPY) and proteinase A (PrA) are synthesized as inactive precursors; upon delivery to the vacuole, these proenzymes undergo proteolytic processing to generate the mature active enzymes (14, 15, 26, 49) . We and others have recently isolated a number of mutants that exhibit defects in the proper localization and processing of multiple vacuolar hydrolases (1, 40, 42, 43) . These vacuolar protein sorting, or vps, mutants define more than 40 complementation groups. Morphological studies using both light and electron microscopy have revealed at least three distinct groups of vps mutants (2) . The majority of the vps mutants (called class A vps mutants) contain morphologically wildtype (wt) vacuoles. A second class of mutants, class B, is characterized by an altered morphology in which the vacuole is highly fragmented. Mutants in four vps complementation groups exhibit the most extreme abnormalities in vacuole morphology. Electron microscopic analysis has revealed that these cells accumulate many small vesicles but lack any compartment that resembles a wt vacuole. This morphology has been designated class C (2).
* Corresponding author.
The class C vps mutants exhibit extreme defects in the sorting and processing of soluble vacuolar proteins. In these strains, the Golgi-modified forms of CPY, PrA, and proteinase B accumulate and are secreted. Little or no mature forms of these vacuolar enzymes can be detected in these mutants. Unlike other vps mutants, these class C strains also mislocalize as much as 50% of the activity of a vacuolar membrane enzyme, a-mannosidase (40) . The class C vps mutants exhibit other genetically linked phenotypic defects, including temperature-sensitive (Ts) growth and sensitivity to osmotic stress. However, nonvacuolar functions such as secretion and microtubule assembly, as well as nuclear and mitochondrial structure, appear to be unaffected in these strains (2, 40) .
In an effort to understand the molecular basis for the phenotypic defects exhibited by the class C vps mutants, we have examined in more detail the seven mutants comprising one of these class C complementation groups, vps33. We report here the cloning of the VPS33 gene. This gene is not essential but is required for growth at 37°C. The predicted VPS33 gene product is a relatively hydrophilic protein of -75 kilodaltons (kDa) that shares sequence similarity with a number of ATP-binding proteins. Cell fractionation studies indicate that Vps33p is soluble. We suggest that the VPS33 gene product acts in the cytoplasm to facilitate Golgi-tovacuole trafficking, thereby promoting vacuole assembly.
MATERIALS AND METHODS

Strains and media. Escherichia coli MC1061 [F-araDJ39
A(araABOIC-leu)7679 AlacX74 galU galK rpsL hsdR strA] (4), JM101 [supE thi A(lac-proAB) (F' traD36 proAB lacIq Z M15)] (27) , and DH1 [F-endAl hsdR17 (rK-mK+) supE44 thi-J recAl gyrA96 relAl?] (13) were used for cloning and TrpE-Vps33 fusion protein production. E. coli JF1754 (hsdR CHARACTERIZATION OF Vps33p 4639 metB leuB hisB lac gal) (25) was used in screening plasmids pLB33-313 and pLB33-317. S. cerevisiae parental strains were SEY6210 (MAToL ura3-52 leu2-3,112 his3-A200 trpl-A901 lys2-801 suc2-A9) and SEY6211 (MATa ura3-52 leu2-3,112 his3-A200 trpl-A901 ade2-101 suc2-A9) (40) . vps33 mutant strains SEY33-2, SEY33-4, and SEY33-5 are isogenic with SEY6210 and carry the vps33-2, vps334, and vps33-5 mutations, respectively. SEY33-7, carrying the vps33-7 allele, is isogenic with SEY6211. LBY317 carries a vps33 null mutation and was derived from SEY6210 (see below). Bacterial strains were grown on standard media (28) . Yeast strains were grown on standard yeast extract-peptonedextrose (YPD) or synthetic dextrose (SD) (synthetic minimal, supplemented as necessary) medium (47) .
Materials. Restriction enzymes, T4 DNA ligase, Klenow enzyme, and polyacrylamide gel electrophoresis supplies were purchased from Boehringer Mannheim Biochemicals (Indianapolis, Ind.). Mung bean nuclease and exonuclease III were the products of New England BioLabs (Beverly, Mass.). 5-Fluoroorotic acid was purchased from PCR, Inc.
(Gainesville, Fla.). Isopropyl-p-D-thiogalactoside (IPTG), Autofluor was purchased from National Diagnostics (Manville, N.J.), Freund complete and incomplete adjuvants were purchased from GIBCO Laboratories (Grand Island, N.Y.), and 5(6)-carboxy-2',7'-dichlorofluorescein diacetate (CD CFDA) was purchased from Molecular Probes, Inc. (Eugene, Ore.). Antiserum against CPY was from Klionsky et al. (19) . All other chemicals were purchased from Sigma Chemical Co. (St. Louis, Mo.) or other standard sources.
Genetic and DNA manipulations. Standard recombinant DNA techniques were performed as described previously (23) . Genetic crosses, sporulation of diploids, and dissection of tetrads were performed according to Sherman et al. (47) . Yeast transformations were done by the lithium acetate method of Ito et al. (16) in the presence of 10 p,g of denatured salmon sperm carrier DNA.
Chromosomal DNA was isolated and Southern analysis was performed (23), using DNA fragments containing either the HIS3 gene or the VPS33 gene as a probe. Northern (RNA) analysis (23) was carried out by using the 1.1-kilobase (kb) ClaI-SmaI VPS33 fragment as a probe, and total RNA was isolated as described by Eakle et al. (9) . DNA probes were labeled by using the Amersham Multiprime DNA labeling system. Vectors and plasmid constructions. E. coli plasmids pBluescript KS (+) and (-) are described in the Stratagene (La Jolla, Calif.) catalog. The yeast-integrating vector pPHYI10 (TRPI, selectable marker) and the E. coli-yeast shuttle vectors pPHYC16 and pPHYC18 (CEN4 ARS1 URA3) will be described elsewhere (P. Herman, unpublished data). The E. coli-yeast shuttle vector pSEY18 is a derivative of pSEY8 (11) in which the pUC8 polylinker has been replaced with the polylinker of pUC18. The HIS3 gene was isolated as a 1.75-kb BamHI fragment from a plasmid kindly provided by E. Phizicky. The pATH vectors used in the TrpE-Vps33 fusion protein production have been previously described (6) .
The 3.7-kb SalI-XbaI fragment of VPS33 (see Fig. 2B ) was subcloned into the pBluescript KS (+) and (-) vectors to generate pLB33-211 and pLB33-212, respectively. Plasmid pLB33-102, used in the integrative mapping experiment, was constructed by cloning the 5.3-kb SalI-PvuII fragment shown in Fig. 2B into the SalI-SmaI sites of the yeastintegrating vector pPHYI10. Construction of pLB33-313, used in the disruption of VPS33, was achieved by digesting plasmid pLB33-212 with EcoRI to remove the region shown in Fig. 2C , gel purifying the resulting linear DNA away from the two EcoRI fragments, blunting the ends with Klenow enzyme, and inserting the HIS3 gene as a blunted BamHI fragment. Recombinant plasmids were selected directly for the presence of the H1S3 gene in the hisB bacterial strain JF1754 (25) on M63 minimal medium lacking histidine (28) . In a similar manner, the 2.1-kb HindIII-SmaI fragment indicated in Fig. 2C (40) , and vacuole morphology (see below).
The plasmid DNA was also subjected to restriction enzyme analysis. The restriction fragments shown in Fig. 2B were isolated from pLB33-6 and subcloned into the appropriate restriction sites within the polylinker of the E. coli-yeast shuttle vector pPHYC18 to generate plasmids pLB33-20 through pLB33-24. Plasmid pLB33-21 was digested with Sall and KpnI, and exonuclease III was used (50) to generate deletions from the Sall end of the insert. The ends were blunted by using mung bean nuclease and Klenow enzyme and religated to generate deletion plasmids pLB33-41 and pLB33-42. The approximate endpoints of these deletions were determined by restriction analysis.
Two sets of nested deletion templates for sequencing were generated by deleting from the Sall end of the insert in VOL. 10, 1990 pLB33-212 and the XbaI end of the insert in pLB33-211, using exonuclease III (50) . Deletions were also generated from the internal SmaI site in pLB33-211, and additional templates were constructed by cloning the 0.5-kb EcoRI fragment, the 1.5-kb ClaI-XbaI fragment, the 0.4-kb PstIXbaI fragment, the 2.7-kb PstI fragment, and the 1.4-kb HindIlI fragment (see Fig. 2C ) into pBluescript KS (-). Single-stranded template DNA was prepared from these constructs (50) after infection with the helper bacteriophage VCSM13 (Stratagene) , and synthetic primers corresponding to the T3 or T7 promoter sequence were prepared by DNA synthesizer. The sequence of both strands of VPS33 was determined by the dideoxy-chain termination method (46) . DNA sequence and hydropathy analyses (21) were done by using a program written by K. Eakle (unpublished Fig. 2B and C) into the appropriate restriction sites of pSEY18. In each case, the plasmid was transformed into SEY33-4 and the frequency of temperature-resistant recombinants was scored.
The vps334(Ts) mutation was rescued by using doublestranded gap repair (33) Antibody production. trpE-VPS33 gene fusions were constructed by using the two fragments of the VPS33 gene depicted in Fig. 2C . The 0.7-kb HindIII-SmaI fragment was isolated from pLB33-21, blunted by using Klenow enzyme, and ligated to the blunted SalI site of the pATH3 vector to generate an in-frame fusion encoding aa 379 to 608 of Vps33p. The 0.5-kb EcoRI fragment was isolated, blunted as described above, and ligated into the SmaI site of the pATH2 vector to generate an in-frame fusion encoding aa 140 to 303 of Vps33p. Individual transformants were purified, and the presence and orientation of the VPS33 sequence was confirmed by restriction analysis. Bacterial strains carrying candidate fusion constructs were assayed for the production of fusion protein (48) . Whole-cell lysates and insoluble fractions were prepared basically as described by Kleid et al. (18) (except that 2% Triton X-100 was used rather than 0.2% Nonidet P-40) and subjected to sodium dodecyl sulfate-9% polyacrylamide gel electrophoresis (22 Immunoprecipitation. Cells were grown in SD medium (47) supplemented with the appropriate amino acids. Whole cells (1.5 U at an optical density at 600 nm of 1.0) were collected by centrifugation. The cells were resuspended in 0.5 ml of the same medium, and 125 ,uCi of Tran35S label was added. The cells were labeled for 20 min with shaking at the appropriate temperature. A 30-min chase was initiated by the addition of methionine to a final concentration of 4 mM. The chase was terminated, and cells were lysed and subjected to a single round of immunoprecipitation, using antiserum specific for Vps33p or CPY as described previously (9, 19) .
Cell fractionation. Cells were grown in SD medium (47) as described above. Six units of cells at an optical density at 600 nm of 1.0 were harvested by centrifugation and spheroplasted in the same medium as described previously (40) . Spheroplasts were labeled and chased as described above. All subsequent manipulations were performed at 4°C. Labeled spheroplasts were pelleted at 1,200 x g for 2 min. The spheroplasts were suspended in 1 ml of lysis buffer (50 mM Tris chloride [pH 7.5], 1 mM EDTA, 5 mM MgCl2, 1 mM phenylmethylsulfonyl fluoride, 1 ,uM leupeptin, 1 mM sodium azide, 0.125 mg of a2-macroglobulin per ml) with various concentrations of KCI as indicated and vortexed for 30 s. In some experiments, the lysis buffer also contained 0.3 M mannitol or 0.8 M sorbitol for partial osmotic support (29, 45) . Unlysed spheroplasts were removed by centrifugation at 500 x g for 2 min and subjected to a second round of lysis. Unlysed spheroplasts were removed as before, and the lysates were pooled and immediately centrifuged at 100,000
x g for 90 min. The pellet was rinsed gently with 1 ml of lysis buffer and suspended in 1 ml of 0.5% sodium dodecyl sulfate. Supernatant and pellet fractions were precipitated with trichloroacetic acid (5% final concentration) and immunoprecipitated.
Fluorescent labeling of cells and microscopy. Cells were grown in YPD, labeled with CDCFDA or fluorescein isothiocyanate (FITC), and observed as described previously (2, 37, 38) .
GenBank accession number. The GenBank accession number for the sequence reported in this paper is M34638.
RESULTS Cloning and genetic analysis of the VPS33 gene. The VPS33 gene was cloned by complementation of the vps33-2(Ts) mutation (in the Ura3-strain SEY33-2) with a yeast genomic library carried on the single-copy vector YCp5O (41 
A:
Xb Xh S C C Xh Sm Xb remained temperature resistant, indicating that the temperature resistance was not dependent on the presence of the plasmid. The remaining two transformants were temperature sensitive when cured, suggesting that the temperature-resistant phenotype was indeed conferred by the plasmid. Restriction analysis of the purified plasmid from these two transformants revealed that the two complementing plasmids contained identical inserts. Retransformation of SEY33-2 and two other vps33 strains demonstrated that this plasmid, designated pLB33-6, complemented all of the phenotypes associated with the vps33 mutations, including temperature sensitivity ( Fig. 1) , mislocalization of vacuolar proteins (see Fig. 5 ), osmotic sensitivity, and the defect in vacuole biogenesis (data not shown).
A restriction map of the 12-kb insert in pLB33-6 is shown in Fig. 2A . Subcloning and complementation analysis (Fig.  2B ) indicated that the complementing activity resided on a 3.7-kb SalI-XbaI fragment. Removal of as much as 1,000 base pairs (bp) from the Sall end, using exonuclease III, did not destroy the ability to complement.
To confirm that this complementing ability was not due to suppression by another gene, we carried out integrative Northern analysis was performed, using an internal fragment of VPS33 as a probe to identify the VPS33 transcript. Consistent with the ORF size predicted from the DNA sequence, a single RNA species of 2.2 kb was detected (data not shown).
The sequence of the predicted VPS33 gene product was subjected to hydropathy analysis according to the model of Kyte and Doolittle (21) . The predicted Vps33 polypeptide is hydrophilic (26% charged amino acids), with no apparent hydrophobic domains that could span a membrane or function as a signal sequence (data not shown). A search for sequence homology using the GENEMBL data bank and the TFASTA algorithm (36) Further homology searches using the GenBank, EMBL, NBRF, and SWISS-PROT protein data bases uncovered no additional significant sequence similarities (36) . However, a manual search of the predicted amino acid sequence revealed two regions of sequence similarity with a number of known and predicted ATP-binding proteins. These two areas of similarity are conserved in a diverse assortment of ATPases and ATP-binding proteins, including the E. coli ATPase a and i subunits, myosin, and phosphofructokinase (Fig. 4) , and a consensus sequence has been determined (53). The two domains are often separated by 60 to 100 aa, and some proteins (e.g., myosin and phosphofructokinase) contain only one of the two regions. In Vps33p, the two regions are located at residues 480 to 498 and 661 to 679 (Fig. 3) .
Disruption of VPS33. Disruption of the VPS33 locus was accomplished by using the one-step gene disruption technique (44) with two different constructions. In the first, the 700-bp EcoRI fragment shown in Fig. 2C was replaced with the HIS3 gene. This disrupted VPS33 construction was digested with Sall and XbaI and used to transform the parental his3-A200 diploid SEY6210/SEY6211. Two different resulting His' transformants were subjected to tetrad analysis. In each of the 10 asci examined, all spores were viable but a segregation pattern of 2 temperature-sensitive His+:2 temperature-resistant His-spores was observed. Microscopic examination of the temperature-sensitive segregants streaked on YPD revealed that the cells doubled at most two times at 37°C. A second construction replaced the entire 2.1-kb HindIII-SmaI fragment (indicated in Fig. 2C ) with the HIS3 gene. This construction deleted all but the carboxyterminal 250 bp of the putative VPS33 ORF. Transformation of the haploid strain SEY6210 with the linear SalI-XbaI fragment carrying this construction yielded temperaturesensitive His+ transformants. The temperature-sensitive phenotype of one such transformant, LBY317, is shown in Fig. 1 . In liquid media, this strain doubles 1.5 times at 37°C
and exhibits a terminal arrest phenotype in which, after 24 h at 37°C, approximately 50% of the cells contain a medium or large bud and an additional 20% contain two or more buds. Southern analysis of the chromosomal DNA from these disrupted strains confirmed the removal of the VPS33 sequences and the integration of the HIS3 gene at the VPS33 locus as expected (data not shown). From these results, we conclude that VPS33 is not essential at low temperatures but is required for growth at 37°C.
As expected, disruption of the VPS33 gene also led to the other phenotypic defects associated with the original mutant alleles. Strains harboring a disrupted VPS33 gene exhibited extreme defects in vacuole morphology and in vacuole protein localization and processing at the permissive temperature (Fig. 5) . The vps33 null mutant strain LBY317 was radioactively labeled at 25°C for 20 min and chased for 30 min before immunoprecipitation with antiserum specific for the vacuolar protease CPY. CPY was present almost exclusively in the precursor form in these cells (Fig. 5, lane 2) , whereas in wt cells labeled under identical conditions, 100% of the CPY was present in the mature vacuolar form (lane 1). Previous characterization of vps33 mutants has demonstrated that most (>70%) of the precursor CPY is secreted from the cell (40) . The Vps-defect exhibited by the null VOL. 10, 1990 CHARACTERIZATION OF Vps33p   4643   1  GTCAAGAAOC 000CTTOOC  GCCATAAT0G AAGATTTAGA TGT =MAA GTOOAATTAC GTCATTTTGA GMA0ACTTTT AAAOGAATTG CTAGGO0OAT 100   101  TACTCCAGAA ATGCTCTCTT ATTATGAAGR GTTTGCTCTA AGAAGCOTT CATCTTCGTA AOCTTOTTCA TAGTCALATTC TTTTCCTTTG TGTGCTCAAT 200  201   AATAGTAGALT AGAMATTATA CTCAACTOM GTCATTTTGT ATAATATATT__MTCACTTCA CACGAACATA CATAAATAAA ATATCATAAA OOTTAGCAAA 300   301   TTOGGACTAG TTATATGTTA ATTAGTTAAA AGOATAGAAAA TTCOAGAAAG G&AGAAAAAG CTGATATTGC CCALTCTCCAA CTTTATCAAA TCATTTCACG 400   401 ATO AALT AGA TTT TOG AAT ACT MAG AAA TTT TCAL TTA ACA AAT GCC OALT GGA CTA TGT OCT ACC TTA AAT GALG ATA TOT CAA AAT OILT GAA (6) to generate in-frame (Fig. 6, lane 1) . This protein was -20-fold more abundant fusions to the trpE gene of E. coli. These fragments (Fig. 2C) when 4. Comparison of the predicted Vps33p sequence with known and predicted ATP-binding proteins. The deduced amino acid sequence of Vps33p shares similarity with the proteins listed through the two domains shown. Residues that are highly conserved at a given position are shown in boldface and boxed. and a consensus sequence is indicated above each domain. The significance of the starred lysine in domain A is discussed in the text. In domain B, asterisks denote hydrophobic residues; this region is followed by an aspartic acid in one of the next three positions in each of the proteins listed (53) . The sequences shown are taken from Walker et al. (53) (56) , the yeast Secl8p (9) is also predicted to bind ATP. suggests that the turnover rate for Vps33p is relatively slow; after a 30-or 90-min chase, there was no significant difference in the amount of the protein produced from a multicopy plasmid. Comparison with CPY indicates that the VPS33 gene product is present at very low levels in wt yeast cells. By densitometric quantitation, we estimate that the production of Vps33p from the multicopy plasmid is comparable to the level of expression of CPY from the chromosomal locus (0.05 to 0.1% of the total cell protein). Cells were also labeled in the presence of tunicamycin, an inhibitor of N-linked glycosylation (10) . The size of Vps33p was unaffected by the drug (Fig. 6, lanes 3 and 4) , indicating that none of the seven potential sites for N-linked carbohydrate addition (24) (Asn-X-SerlThr) is utilized.
The subcellular localization of Vps33p was examined by cellular fractionation and immunoprecipitation studies.
Wild-type cells carrying VPS33 on a multicopy plasmid were converted to spheroplasts, radioactively labeled, and osmotically lysed under a variety of conditions before being subjected to centrifugation at 100,000 x g for 90 min. These centrifugation conditions were sufficient to pellet >95% of the vacuolar membrane protein alkaline phosphatase, whereas the cytosolic marker enzyme glyceraldehyde 3- (38) and FITC (37) , that accumulate in this organelle. As previously mentioned, most of the class C vps mutants exhibit extreme defects in vacuole morphology in that they contain no compartments that resemble wt vacuoles. Instead, they accumulate many small vesicles and other membranous structures (2) . When these class C vps mutants are stained with CDCFDA or FITC, only small speckles of fluorescence are detected. Two vps33 mutant strains, SEY33-4 and SEY33-5, however, do not exhibit these gross abnormalities in their vacuole morphologies. Instead, they contain vacuoles that stain like those in wt cells. Unlike the other, more extreme vps33 mutants, these strains also are not sensitive to osmotic stress. Furthermore, SEY33-4 and SEY33-5 are only moderately defective in vacuole protein localization, missorting -40% of the soluble vacuolar protease CPY. One of these strains, however, is temperature sensitive for growth. This strain, SEY33-4, was found to contain morphologically wt vacuoles, as visualized by using either CDCFDA or FITC, in both the mother cell and the bud at 25C, the permissive temperature ( Fig. 8A and B) . However, when the strain was shifted to the nonpermissive temperature (37°C) for 2 h, budding cells were observed in which the bud did not appear to have any stain (Fig. 8C and D) . Incubation for longer times at 37°C resulted in fewer buds with detectable vacuole staining ( Fig. 8E to J) . By 6 h after the shift to 37°C, only a small fraction of the buds had vacuole fluorescence, and some unbudded cells exhibited a typical class C phenotype in that little or no vacuole fluorescence was visible (Fig. 8J) . The wt parental strain SEY6210 is shown for comparison in Fig. 8K and L. Under identical staining conditions, bud vacuole fluorescence was clearly visible in these cells at 25°C (Fig. 8K) or after 6 h at 37°C (Fig. 8L) . The extent of the bud vacuole staining defect in SEY33-4 was quantitated (Fig. 8) . When SEY33-4 was grown at 25°C, 80% of the buds examined contained vacuole fluorescence. After 6 h at 37°C, only 14% of the buds exhibited vacuole staining. The vacuole protein processing phenotype of SEY33-4 was also exacerbated by exposure to 37°C. After 6 h at 37°C, -70% of the CPY accumulated in the precursor form, as compared with 40% at 25°C (Fig. 9B; compare lanes 2 and 6) . The temperature-sensitive mutation and the bud vacuole defect in SEY33-4 are genetically linked to the vacuole protein processing defect (2, 40) , and each of the defects is completely complemented by the cloned VPS33 gene.
The vps334(Ts) mutation results in a Leu-646 -* Pro change. The temperature-sensitive mutation in SEY33-4 was mapped by using a strategy of recombinational rescue. Initially, SEY33-4 was transformed with the noncomplementing plasmid pLB33-23 or pLB33-24 (Fig. 2B) ; transformants streaked on YPD plates were incubated at 37°C, and the presence or absence of temperature-resistant colonies was scored. Many temperature-resistant recombinants were obtained from SEY33-4 harboring pLB33-23, indicating that the temperature-sensitive mutation likely lies 3' of the ClaI site within the ORF. Various fragments containing this region of the VPS33 gene were subcloned into the multicopy vector pSEY18, and SEY33-4 transformants carrying these plasmids were again scored for the frequency at which temperature-resistant revertants arose. The results of this analysis (data not shown) suggested that the temperaturesensitive mutation mapped to the 250-bp region between the SmaI site and the end of the ORF (Fig. 2C) . The chromosomal mutation was recovered by transforming SEY33-4 with a replicating plasmid carrying VPS33 containing a double-stranded gap between the SmaI and XbaI sites (33) . Sequencing of the SmaI-XbaI fragment from the rescued plasmid revealed that a single base pair change within the ORF, resulting in a leucine-to-proline change at residue 646, was responsible for the temperature sensitivity. The predicted amino acid sequences of the wt VPS33 gene product and the mutant Vps33p carrying the Leu-646 --Pro alteration were subjected to Chou-Fasman analysis (5). The presence of proline at position 646 is predicted to cause a structural change in the VPS33 gene product, inserting a turn in a region that is expected to form a random coil in the wt protein.
The nature of the temperature sensitivity was examined by retransforming various wt and vps33 strains with the vps33 gene carrying the rescued temperature-sensitive mutation on single and multicopy vectors. Transformation of SEY33-4 with a second copy of the temperature sensitive mutant allele resulted in a strain which grew slightly better at 37°C than did the original mutant. A null mutant carrying the vps334 mutant allele on a single-copy vector had a growth rate comparable to that of the original mutant allele. Both mutants exhibited wt growth at 37°C when the temperaturesensitive allele was present on a multicopy vector. Transformation of the wt strain SEY6210 with either the single-copy or the multicopy construction did not affect its ability to VOL. 10, 1990 ' . : , , : " . ' E E g , ' , : . . . S . , ' > -, ' , . -. ; , S l , . l , ' . e , . 0 , ' . . . , , , . , , , . , . , . , , . , . , . . . . , . a R , * X , . . , s , . , . 4 h (E and F), or 6 h (G to J) before harvesting. Also shown for comparison is the parental strain SEY6210 grown at 25°C (K) and shifted to 37°C for 6 h (L). Cells were stained with FITC as described in Materials and Methods and observed by using Nomarski (left) or fluorescence (right) optics. The number of buds exhibiting vacuole fluorescence was quantitated and expressed as a percentage of the total number of large budded cells (n). Cells were grown at 25°C, incubated at 37°C for the indicated lengths of time, and stained with FITC as described above.
Bar, 10 ,Lm. grow at 37°C (Fig. 9A) . Thus, the mutant allele vps334(Ts) is recessive to the wt allele even when overproduced. Furthermore, strains carrying the vps334 mutant allele appeared to exhibit a dosage-dependent growth phenotype; overexpression of the mutant allele resulted in complementation of the temperature-sensitive defect of the null mutant or SEY33-4. However, although the strains carrying multiple copies of vps334 were temperature resistant, they still exhibited a partial Vps-phenotype. Immunoprecipitation experiments indicated that 15% of the CPY accumulated in the precursor form in SEY33-4 carrying the temperature-sensitive allele on a multicopy plasmid (Fig. 9B) (Fig. 6) . In cell fractionation experiments, Vps33p behaves as a soluble cytoplasmic protein under a variety of lysis conditions (Fig. 7) . The hydro-1-s philic nature of the predicted amino acid sequence and the apparent lack of N-linked glycosylation (Fig. 6 ) are consistent with a cytoplasmic location for Vps33p.
The predicted amino acid sequence of Vps33p possesses two regions of similarity with a number of ATPases and _~4 ATP-binding proteins (Fig. 4) . Several studies suggest that these domains are directly involved in nucleotide binding or enzyme function. The conserved lysine residue in adenylate 6 kinase, marked with an asterisk in Fig. 4 interact with ATP (7, 12, 51) , and mutagenesis of the --61kd corresponding lysine in the E. coli ATPase a or i subunit impaired apparent ATP-binding and catalytic activity (34, 39 (Fig. 8 ) and the vacuolar protein processing defect is ne. The strain exacerbated (Fig. 9) . The temperature-sensitive defect in iflysine, argithis strain is due to a single base pair substitution which leiotropic de- results in a leucine-to-proline change at position 646 10, 1990 in which Vps33p acts primarily in Golgi-to-vacuolar protein transport. The observation that Vps33p fractionates as a cytosolic protein suggests that this protein is not a structural component of the vacuole itself. In addition, the existence of SEY33-4 and a second vps33 strain, SEY33-5, that mislocalize CPY yet contain apparently normal vacuoles at 25°C is inconsistent with a structural function for Vps33p in maintaining vacuole integrity. A primary role for Vps33p in vacuole inheritance also seems unlikely, given that SEY33-4 and SEY33-5 exhibit apparently normal vacuole segregation patterns during cell division at the permissive temperature. These observations suggest that the primary defect in these mutants lies in Golgi-to-vacuole trafficking. If Vps33p were directly involved in vacuole inheritance or vacuolar structure, mutants that clearly affect vacuole protein localization would also be expected to exhibit morphological abnormalities in the vacuole.
The simplest explanation for the extreme abnormalities in vacuole morphology exhibited by most of the vps33 mutants is that as a consequence of a primary defect in Golgi-tovacuole protein transport, proteins necessary for vacuolar inheritance or structural stability are mislocalized. In strong vps33 mutants, which exhibit partial missorting of a vacuolar membrane component as well as almost completely aberrant targeting of soluble hydrolases, vacuole assembly is severely impaired. The less defective mutant SEY33-4 appears to contain a partially functional Vps33p. The residual activity is sufficient to permit some Golgi-to-vacuole protein transport and thus the formation of nearly normal vacuoles. The lack of a vacuole in the bud at 37°C may reflect a more complete loss of function if, for example, the mutant protein is less stable at high temperatures. We cannot exclude, however, the possibility that the VPS33 gene product is bifunctional, with roles in both vacuole protein targeting and vacuole maintenance or segregation to emerging buds. In this scenario, the protein encoded by the vps334 allele might be defective in only the former function at 250C but both functions at 37°C.
A possible role for Vps33p in Golgi-to-vacuole sorting is suggested by a recent observation that the protein is phosphorylated in vivo (P. Herman, J. Stack, and S. Emr, unpublished observations). Perhaps Vps33p undergoes a cycle of phosphorylation-dephosphorylation, which in turn regulates its activity in promoting Golgi-to-vacuole protein transport. Since this transport is assumed to be vesicle mediated, the VPS33 gene product could act at the level of vesicle formation, transport, or fusion with the target organelle. The accumulation of many small vesicles in vps33 mutant cells (2) suggests that the defect in these strains may occur after vesicle formation. Using the probes developed in this study in conjunction with an in vitro assay for protein transport from the Golgi to the vacuole (T. A. Vida, T. R. Graham, and S. D. Emr, submitted for publication), we hope to determine the step(s) at which Vps33p acts as well as the significance of the observed phosphorylation.
